PLOS
open access
CC BY 4.0
Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness#837823
- Gemigliptin, Dapagliflozin, Empagliflozin DDI Study#1164379
- A Rapid and simple method for quantifying rezafungin in human plasma#1158336
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions#28558
- Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.#474894
Record · ID 313061
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive